Key result
Aspirin increased template bleeding time by 61% and PFA-100 closure time by 79% compared to placebo, with the PFA-100 producing less variable effects and fewer false positive results.
Why the study?
Does aspirin affect closure time measured by PFA-100 compared to template bleeding time in healthy volunteers?
RCT (n=12)
double-blind
randomized
Does aspirin affect closure time measured by PFA-100 compared to template bleeding time in healthy volunteers?
The PFA-100 closure time is as sensitive as the template bleeding time for detecting aspirin's effect on platelet function, but with less variability and fewer false positives.
Answers are grounded in this paper and cite their sources.
PFA-100 may be preferred over template bleeding time for aspirin monitoring; confirms superior reproducibility in RCT evaluation.
AIMS: The aim of this study was to compare the effects of aspirin on platelet function as measured by the 'classical' template bleeding time with a new ex vivo method measuring closure times using the PFA-100 machine. Platelet aggregation in response to arachidonic acid was also measured ex vivo. METHODS: The trial was a randomized, double-blind, placebo-controlled crossover design, with each volunteer taking 750 mg aspirin (BP) or placebo, three times a day for 5 days, with an 18 day wash-out period between treatments. Bleeding times and closure times were measured before the first dose on the first day and 0.5 h after the last dose on the fifth day of each treatment period. They were also measured 2 weeks after the last day of the trial. RESULTS: Baseline bleeding times (pre-placebo) were 415 s using the Simplate, whilst baseline closure times were 115 s using the PFA-100. Aspirin treatment caused an increase of both the template bleeding time (61%) and the closure time of the PFA-100 (79%) when compared with the effects of placebo. The platelet aggregatory response to arachidonic acid was completely inhibited following aspirin treatment and was unaffected following placebo. Two weeks after the end of the trial, all values had returned to pre-treatment levels. The template bleeding time was unaltered in 1 of the 12 volunteers during aspirin treatment and was significantly prolonged in 3 of the 12 volunteers during placebo treatment. The PFA-100 closure time was unaltered in 1 of the 12 volunteers during aspirin treatment and was prolonged in 1 subject during placebo treatment. CONCLUSIONS: The change in closure time using the PFA-100 is as sensitive and reproducible to the effects of aspirin on platelet function as is the template bleeding time test. However, the PFA-100 produced less variable effects with fewer false positive results.
No takes yet. Share an insight, caveat, or question.
Marshall et al. (1997) conducted an RCT in healthy volunteers (n=12). aspirin vs. placebo was evaluated on platelet function measured by template bleeding time and PFA-100 closure time. Aspirin increased template bleeding time by 61% and PFA-100 closure time by 79% compared to placebo, with the PFA-100 producing less variable effects and fewer false positive results.
Synapse has enriched 10 related papers. Consider them for comparative context: